Saturday, August 22, 2026
19.3 C
Bengaluru

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆 Market Movers – Top 5 Brands by Value RankBrandCompanyTherapy Area₹ Value Cr% GrowthEI1AugmentinGSKAI69.8-1.2%94%2PANAlkemGI68.827.3%114%3LIV.52HimalayaGI68.620.2%108%4Glycomet GPUSVAnti-Diabetic67.74.4%100%5PAN DAlkemGI57.132.9%119% Key Takeaway: GI and Anti-Diabetic therapies are dominating value and growth. Alkem is out-executing everyone. 📊 Therapy Area Heatmap – What’s Winning? 🧪 Gastrointestinal (GI) – Booming PAN / PAN D…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img